Real-World Evidence Circles

Directions Website

Real-World Evidence Circles Circles: Reimagining and democratizing medical research. Impactful clinical, scientific and financial return on investment.

Ethical intermediation between industry and providers. We license the patented cloud-based software platform necessary to capture, aggregate, analyze and use RWE. That platform integrates the powerful user experience of inCytes™ for physicians and Benchmarc™ for their patients. We also provide the processes enabling physicians and industry to generate clinical, professional and financial value from RWE with minimal burden. Circles-based RWE solutions are turnkey, flexible, and cost effective. They are tailored to the strategic objectives of our clients, and deliver demonstrable and sustained return on investment. They represent a profit center, not a cost center.

Healthcare has spent years solving for privacy, compliance, and security. But what if the next challenge is trust?As hea...
11/12/2026

Healthcare has spent years solving for privacy, compliance, and security. But what if the next challenge is trust?

As healthcare becomes increasingly data-driven, the organizations that create value with patients, not just from patients, may have the greatest advantage. Our latest article explores why respect could become the foundation of the next healthcare economy:

Circle encodes reciprocity and recognition into every consent event, turning healthcare data participation into dignity and shared value.

Data doesn't improve  . Understanding the data does.Across the Wickline/Mercuri TKA Circle, patients achieved an average...
11/11/2026

Data doesn't improve . Understanding the data does.

Across the Wickline/Mercuri TKA Circle, patients achieved an average 18.33-point increase in KOOS JR scores within six weeks following total knee replacement. This is significant improvement in a relatively short recovery window. The statistics aren't the destination. They are the starting point.

Behind this observation are 46,333 clinical and outcomes data points collected throughout the recovery journey. Together, those data points allow clinicians and researchers to move beyond measuring outcomes and begin exploring what drives them.

Why are some patients improving faster? Which care strategies appear most effective? What lessons can be applied to future patients? Those answers have the potential to impact far more people than the initial 400 patients represented in the dataset.

Collecting this evidence contains another critical factor: it gives clinicians true data sovereignty. When surgeons own the data they create, they hold the power—and the economic value—to fund their own ongoing research rather than relying on institutional gatekeepers. The goal of outcomes collection isn't documentation. It's discovery—and discovery is what leads to better care.

The biggest challenge in healthcare data may not be privacy. It may be consent.As data becomes more valuable and more co...
11/10/2026

The biggest challenge in healthcare data may not be privacy. It may be consent.

As data becomes more valuable and more connected, traditional consent models are struggling to keep pace. Our latest article examines why the future of ethical data governance depends on consent that is dynamic, transparent, and continuously respected:

Circle Datasets turn consent from a one-time signature into a living, revocable system, enforced in real time across federated healthcare data.

𝗪𝗵𝗮𝘁 𝗶𝗳 𝘁𝗵𝗲 𝗯𝗶𝗴𝗴𝗲𝘀𝘁 𝗰𝗼𝘀𝘁 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝘀𝗻'𝘁 𝘄𝗵𝗮𝘁 𝘄𝗲 𝗴𝗲𝘁 𝘄𝗿𝗼𝗻𝗴, 𝗯𝘂𝘁 𝘄𝗵𝗮𝘁 𝘄𝗲 𝗻𝗲𝘃𝗲𝗿 𝗶𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗲?Every unanswered question ...
11/06/2026

𝗪𝗵𝗮𝘁 𝗶𝗳 𝘁𝗵𝗲 𝗯𝗶𝗴𝗴𝗲𝘀𝘁 𝗰𝗼𝘀𝘁 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝘀𝗻'𝘁 𝘄𝗵𝗮𝘁 𝘄𝗲 𝗴𝗲𝘁 𝘄𝗿𝗼𝗻𝗴, 𝗯𝘂𝘁 𝘄𝗵𝗮𝘁 𝘄𝗲 𝗻𝗲𝘃𝗲𝗿 𝗶𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗲?

Every unanswered question carries a price, from wasted resources to missed opportunities to improve patient care. Our latest article explores why neglecting evidence gaps may be more expensive than we realize.

Read more in the article: https://www.rgnmed.com/post/the-cost-of-neglect

Underfunded medical questions carry the highest hidden cost. See how measuring neglect could redirect research toward high-impact evidence.

Most healthcare organizations are sitting on a hidden liability.Data fuels research, AI, regulatory submissions, and com...
11/03/2026

Most healthcare organizations are sitting on a hidden liability.
Data fuels research, AI, regulatory submissions, and commercial decisions. Yet much of it cannot be fully verified, creating delays, compliance challenges, and costly inefficiencies.

Our latest article explores why verified data is becoming one of healthcare's most valuable assets, and how the ability to prove the integrity of data may soon matter more than the volume of data collected.

Read the full article:

Circle turns verified healthcare data into a reusable, compounding asset, cutting compliance costs and accelerating regulatory and AI timelines.

𝗧𝗵𝗲 𝗯𝗲𝘀𝘁 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗿𝗮𝗿𝗲𝗹𝘆 𝗰𝗼𝗺𝗲 𝗳𝗿𝗼𝗺 𝗮 𝘀𝗶𝗻𝗴𝗹𝗲 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲.They emerge when physicians pool knowledge and learn from ...
10/29/2026

𝗧𝗵𝗲 𝗯𝗲𝘀𝘁 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗿𝗮𝗿𝗲𝗹𝘆 𝗰𝗼𝗺𝗲 𝗳𝗿𝗼𝗺 𝗮 𝘀𝗶𝗻𝗴𝗹𝗲 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲.

They emerge when physicians pool knowledge and learn from a broader patient population. The Wickline/Mercuri TKA Circle now includes 𝟭𝟰 𝗶𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗼𝗿𝘀 contributing outcomes and clinical data from real-world knee replacement patients. Together, they’ve documented an average 𝟭𝟴.𝟯𝟯-𝗽𝗼𝗶𝗻𝘁 𝗶𝗺𝗽𝗿𝗼𝘃𝗲𝗺𝗲𝗻𝘁 𝗶𝗻 𝗞𝗢𝗢𝗦 𝗝𝗥 𝘀𝗰𝗼𝗿𝗲𝘀 𝘄𝗶𝘁𝗵𝗶𝗻 𝘀𝗶𝘅 𝘄𝗲𝗲𝗸𝘀 𝗮𝗳𝘁𝗲𝗿 𝘀𝘂𝗿𝗴𝗲𝗿𝘆.

This finding raises important questions: What are these patients doing differently? What can clinicians learn from their recovery journeys? And how can those lessons be applied more broadly?

The larger the network of participating physicians, the greater the opportunity to identify patterns that might otherwise remain invisible. Better outcomes don't happen simply because data is collected. They happen when clinicians learn from the data together.

But there’s another critical dimension: who actually owns that progress?

Too often, valuable clinical insights are absorbed by third-party platforms without any return to the practices that generate them. With the Wickline/Mercuri Circle, participating physicians retain full sovereignty over their clinical data—including the ability to share in dataset licensing and monetization.

By building this network together, we aren’t just advancing orthopedic science. We are creating a high-value, physician-owned dataset that is both a clinical asset and an economic one.

That’s where collaboration becomes both progress and enterprise.

Comment below or send us a message to learn how to join, retain your data rights, and contribute to the Circle.

Ethics isn't a cost of doing business. It's becoming a competitive advantage.As healthcare organizations invest in AI,  ...
10/28/2026

Ethics isn't a cost of doing business. It's becoming a competitive advantage.
As healthcare organizations invest in AI, , and advanced analytics, trust is emerging as a key differentiator. The organizations that prioritize transparency, accountability, and responsible innovation will be the ones best positioned to succeed.

Read our latest perspective on why ethics belongs in every growth strategy: https://www.rgnmed.com/post/ethics-as-a-competitive-advantage

Ethics is a competitive edge in healthcare data. See how embedded transparency and verifiable integrity build lasting trust and market resilience.

Most organizations don't discover data problems until it's too late.See why the future of healthcare depends on making d...
10/22/2026

Most organizations don't discover data problems until it's too late.

See why the future of healthcare depends on making data trustworthy from the moment it's collected.
Read more: https://www.rgnmed.com/post/data-integrity-by-design

Circle builds data integrity into healthcare architecture, with cryptographic proof and immutable audit trails that make compliance native.

𝐂𝐌𝐒 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐞𝐬 𝐒𝐮𝐛𝐬𝐭𝐚𝐧𝐭𝐢𝐚𝐥 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐁𝐞𝐧𝐞𝐟𝐢𝐭 𝐚𝐭 𝟏𝟐 𝐦𝐨𝐧𝐭𝐡𝐬. 𝐌𝐎𝐓𝐈𝐕™ 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐫𝐞𝐚𝐜𝐡𝐞𝐝 𝐢𝐭 𝐢𝐧 𝟗𝟎 𝐝𝐚𝐲𝐬.Surgeons and facilities f...
10/20/2026

𝐂𝐌𝐒 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐞𝐬 𝐒𝐮𝐛𝐬𝐭𝐚𝐧𝐭𝐢𝐚𝐥 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐁𝐞𝐧𝐞𝐟𝐢𝐭 𝐚𝐭 𝟏𝟐 𝐦𝐨𝐧𝐭𝐡𝐬. 𝐌𝐎𝐓𝐈𝐕™ 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐫𝐞𝐚𝐜𝐡𝐞𝐝 𝐢𝐭 𝐢𝐧 𝟗𝟎 𝐝𝐚𝐲𝐬.

Surgeons and facilities face mounting regulatory pressures under the mandatory THA/TKA PRO-PM. Our live registry demonstrates what happens when high-performing surgical pathways meet standardized data capture:

𝐏𝐫𝐞-𝐎𝐩: 52.7 (n =362)
𝟐 𝐖𝐞𝐞𝐤𝐬: 65.4 (n = 292) | +𝟏𝟐.𝟕 𝐩𝐭𝐬 (immediate MCID)
𝟔 𝐖𝐞𝐞𝐤𝐬: 70.2 (n = 242) | +𝟏𝟕.𝟓 𝐩𝐭𝐬 (bordering CMS PASS ≥ 71)
𝟑 𝐌𝐨𝐧𝐭𝐡𝐬: 74.0 (n = 172) | +𝟐𝟏.𝟑 𝐩𝐭𝐬 (surpasses CMS 1-yr SCB ≥ 20)
𝟔 𝐌𝐨𝐧𝐭𝐡𝐬: 75.3 (n = 49) | Sustained functional plateaus

𝐓𝐡𝐞 𝐌𝐎𝐓𝐈𝐕™ 𝐏𝐫𝐨𝐭𝐨𝐜𝐨𝐥 & 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞 𝐁𝐨𝐭𝐭𝐨𝐦 𝐋𝐢𝐧𝐞:

Co-authored by Drs. Andrew Wickline and John J. Mercuri, expert-reviewed by Orthopaedic Research and Education Foundation, and published in , the ™ protocol is product-agnostic. While we are still investigating which specific clinical and perioperative variables drive this early acceleration, capturing standardized is vital to elevate care for all patients.

✔️ 𝐃𝐞-𝐑𝐢𝐬𝐤𝐢𝐧𝐠 𝐂𝐌𝐒 𝐑𝐞𝐢𝐦𝐛𝐮𝐫𝐬𝐞𝐦𝐞𝐧𝐭𝐬: Avoid the 25% Medicare APU penalty. While 1-year survey attrition remains a massive liability, MOTIV™ maintains >𝟗𝟎% 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞 𝐚𝐜𝐫𝐨𝐬𝐬 𝐚𝐜𝐭𝐢𝐯𝐞 𝐭𝐢𝐦𝐞𝐩𝐨𝐢𝐧𝐭𝐬, with patients clearing the CMS 1-year clinical benchmark in just 90 days.

✔️ 𝐓𝐫𝐮𝐞 𝐃𝐚𝐭𝐚 𝐎𝐰𝐧𝐞𝐫𝐬𝐡𝐢𝐩: Physicians retain 100% data ownership to build practice equity and support future RWE monetization.

Learn more about the MOTIV™ protocol and how to participate: https://www.rgnmed.com/motiv

(𝘐𝘯𝘵𝘦𝘳𝘪𝘮 𝘶𝘯𝘢𝘥𝘫𝘶𝘴𝘵𝘦𝘥 𝘢𝘯𝘢𝘭𝘺𝘴𝘪𝘴 𝘰𝘧 𝘳𝘰𝘭𝘭𝘪𝘯𝘨 𝘳𝘦𝘨𝘪𝘴𝘵𝘳𝘺 𝘤𝘰𝘩𝘰𝘳𝘵. 𝘋𝘢𝘴𝘩𝘣𝘰𝘢𝘳𝘥 𝘤𝘩𝘢𝘳𝘵 𝘢𝘵𝘵𝘢𝘤𝘩𝘦𝘥.)

LINK TO MOTIV™ PROTOCOL:https://circles.rgnmed.com/hubfs/Unlisted%20Pages/MOTIV%20(OREF)/MOTIV%20Wickline-Mercuri%20TKA/Foundational/MOTIV%20Total%20Knee%20Arthroplasty%20Protocol%20PDF.pdf

CMS bundled-payment mandates like CJR-X are not a pilot.  They represent a strong trend, and are likely to extend to mor...
10/13/2026

CMS bundled-payment mandates like CJR-X are not a pilot. They represent a strong trend, and are likely to extend to more procedures and therapeutic areas.

Beginning January 1, 2028, roughly 2,500 hospitals become accountable for a joint-replacement episode that runs from a 180-day pre-admission risk-adjustment lookback, through the acute stay, to 90 days after discharge. Covered hospitals face four challenges:

1. 𝗖𝗼𝘀𝘁 𝗮𝗻𝗱 𝗰𝗼𝗺𝗽𝗹𝗲𝘅𝗶𝘁𝘆. Monitoring every partner across that span (P*P, pre-op clinic, surgeon, SNF, home health) takes systems and IT infrastructure that are expensive to build and difficult to sustain. For many hospitals, building it internally is not realistic.

2. 𝗧𝗶𝗺𝗶𝗻𝗴. Even when the data can be assembled, it arrives too late. CMS's data feed and final reconciliation come after the performance year ends, when no corrective action remains.

3. 𝗢𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝗽𝗮𝗶𝗿𝘀. CJR-X scores patient-reported outcomes using matched surveys: one within 90 days before surgery, one 300 to 425 days after. Falling short of the minimum defaults that measure to a mediocre score. A low enough Composite Quality Score then forfeits the entire reconciliation payment, however well costs were managed. Separately, hospital-wide completion below 50% cuts the annual Medicare payment update.

4. 𝗙𝗿𝗮𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻. Each partner is responsible for one piece of pre-admission risk-adjustment lookback and the post-discharge care. No one has visibility into the entire episode while it is still running.

RegenMed's patented Circles Platform addresses this with a single architecture spanning pre-op, hospital, post-acute, and patient surveys. Hospitals see quality-score drivers and survey completion during the episode, at lower cost than attempting to assemble a number of point solutions.

More here: https://www.rgnmed.com/post/circles-platform-for-cjr-x

Address

680 S Cache Street Suite 100-8790
Jackson, WY
83001

Alerts

Be the first to know and let us send you an email when Real-World Evidence Circles posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Nearby businesses


Other Biotechnology in Jackson

Show All